FindTrial
Sign In

comparison of PAP smear and VIA for screening of cervical cancer

Comparison of diagnostic value of Visual inspection with acetic acid (VIA) and PAP Smear in screening of cervical cancer. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/08/071936
Enrollment
100
Registered
2024-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A64- Unspecified sexually transmitted disease

Interventions

Intervention1: NIL: NIL Control Intervention1: nil: nil Control Intervention2: NIL : NIL

Sponsors

Dr Meena Chaudhari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: all the patient who are giving consent, icludesEarly marriage Early pregnancy Sexual activity at early age Multi parity Multiple sexual partner Women with STI, leucorrhoea, abnormal vaginal bleeding

Exclusion criteria

Exclusion criteria: Unmarried patients. Patients with bleeding P/V and active infection at the time of examination. Pregnant women. Patients with vaginal pessary

Design outcomes

Primary

MeasureTime frame
sensitivity of VIA compare to Pap smear to identify cervical cancer in women. Timepoint: within month—

Secondary

MeasureTime frame
specificity of the VIA compare to PAP smear to identify cervical cancer.Timepoint: within month—

Countries

India

Contacts

Public ContactDr Meena Chaudhari

Obstetrics and Gynecology department

tiwariaditi085@gmail.com8980806068

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026